Effect of Dapagliflozin on Blood Pressure Variability in Patients With Prediabetes and Prehypertension Without Pharmacological Treatment
Latest Information Update: 29 Jan 2021
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Hypertension; Prediabetic state
- Focus Therapeutic Use
- 01 Dec 2020 Results published in the Blood Pressure Monitoring
- 12 Apr 2020 Status changed from active, no longer recruiting to completed.
- 24 Mar 2020 Planned End Date changed from 30 Nov 2019 to 30 Nov 2021.